References
- Carter S K. Large bowel cancer: The current status of treatment. J Natl Cancer Inst 1976; 56: 3–10
- Cadman E, Heimer R, Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration. Explanation for drug synergism. Science 1979; 205: 1135–1137
- Cadman E, Heimer R, Benz C. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L 1210 cells. J Biol Chem 1981; 256(4)1695–1704
- Benz C, Shoenberg M, Choti M, Cadman E. Schedule dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor lines. J Clin Invest 1980; 66: 1161–1165
- Martin D S, Hogaworth D, Davin E, et al. Methotrexate's activity against human breast cancer correlates with positive activity against a spontaneous murine mammary tumor alone and with 5-fluorouracil. Proc Am Assoc Cancer Res 1976; 17: 130
- Bertino J, Sawicki W, Lindquist C, Gupta V S. Schedule dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res 1979; 37: 327–326
- Bertino J R, Mini E, Fernandes D J. Sequential methotrexate and 5-fluorouracil. Mechanisms of synergy. Sem Oncol 1983; 10: 2–6
- Benz C, Cadman E. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma hct-8. Cancer Res 1981; 41: 994–999
- Myers C E. The pharmacology of the fluoropyrimidines. Pharmacol Res 1981; 33(1)1
- Danenberg P V, Lockskin A. Fluorinated pyrimidines as tight binding inhibitors of thymidylate synthetase. Pharmacol Ther 1981; 13: 69
- Waxman S, Bruchner H, Wagles A, Schreiber C. Increased 5fura cytotoxicity with leucovorin in vitro. Proc Am Assoc Cancer Res 1978; 19: 149
- Weinerman B, Schacter B, Schipper H, et al. Sequential methotrexate and 5 FU in the treatment of colorectal cancer. Cancer Treat Rep 1982; 66: 1553–1555
- Weinerman B, Orr K. The superiority of sequential methotrexate, 5-fluorouracil and leucovorin rescue given by infusion over a bolus schedule in mice with colorectal cancer. Curr Ther Res 1988; 44: 94–99
- Machover D, Goldschmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high dose folinic acid. J Clin Oncol 1986; 4: 685–695
- Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6: 469–475
- Browman G P, Archibald S D, Young J EM, et al. Prospective randomized trial of one hour sequential vs. simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer. J Clin Oncol 1983; 1: 787–792